Mastocytosis is a rare and heterogeneous disease characterized by various clinical and biological features that affect different prognoses and treatments. The disease is usually divided into 2 principal categories: cutaneous and systemic disease (SM). Clinical features can be related to mast cell (MC) mediator release or pathological MC infiltration. SM is a disease often hard to identify, and the diagnosis is based on clinical, biological, histological, and molecular criteria with different specialists involved in the patient’s clinical work-up. Among all manifestations of the disease, gastrointestinal (GI) symptoms are common, being present in 14%-85% of patients, and can significantly impair the quality of life. Here we review the data regarding GI involvement in SM, in terms of clinical presentations, histological and endoscopic features, the pathogenesis of GI symptoms, and their treatment.

Elvevi, A., Elli, E., Luca, M., Scaravaglio, M., Pagni, F., Ceola, S., et al. (2022). Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review. WORLD JOURNAL OF GASTROENTEROLOGY, 28(29), 3767-3779 [10.3748/wjg.v28.i29.3767].

Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review

Scaravaglio M.;Pagni F.;Ceola S.;Invernizzi P.;Massironi S.
2022

Abstract

Mastocytosis is a rare and heterogeneous disease characterized by various clinical and biological features that affect different prognoses and treatments. The disease is usually divided into 2 principal categories: cutaneous and systemic disease (SM). Clinical features can be related to mast cell (MC) mediator release or pathological MC infiltration. SM is a disease often hard to identify, and the diagnosis is based on clinical, biological, histological, and molecular criteria with different specialists involved in the patient’s clinical work-up. Among all manifestations of the disease, gastrointestinal (GI) symptoms are common, being present in 14%-85% of patients, and can significantly impair the quality of life. Here we review the data regarding GI involvement in SM, in terms of clinical presentations, histological and endoscopic features, the pathogenesis of GI symptoms, and their treatment.
Articolo in rivista - Review Essay
Gastrointestinal involvement; Gastrointestinal symptoms; Systemic mastocytosis;
English
7-ago-2022
2022
28
29
3767
3779
none
Elvevi, A., Elli, E., Luca, M., Scaravaglio, M., Pagni, F., Ceola, S., et al. (2022). Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review. WORLD JOURNAL OF GASTROENTEROLOGY, 28(29), 3767-3779 [10.3748/wjg.v28.i29.3767].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/427906
Citazioni
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
Social impact